The European Union has granted CE mark approval to Venaxis's blood-based test which is designed to identify patients at low risk for acute appendicitis. The APPY1 test, which is being initially developed for pediatric, adolescent and ...
Tags: blood based test, acute appendicitis, young adult patients
Eli Lilly and Company has reassumed the worldwide development and commercialization rights for novel basal insulin analog giving a scope to diabetes alliance signed with Boehringer concerning LY2605541. Lilly also considers initiating ...
Tags: Eli Lilly, commercialization rights, Boehringer, company news
Tranzyme Pharma has completed the chemistry-based drug discovery partnership and transferred the resulting compounds to Bristol-Myers Squibb to advance the development. The strategic collaboration leveraged Macrocyclic Template Chemistry, ...
Tags: Tranzyme Pharma, chemistry based drug, chemistry technology, company news
The US Food and Drug Administration (FDA) has granted 510(k) approval to Alphatec Holdings' new products, Pegasus and ILLICO FS Facet Fixation systems. Pegasus, an anchored anterior cervical interbody device, offers single-step deployment ...
Tags: MIS Systems, Alphatec, FDA Approval, New Anterior Cervical Interbody
Japan's biggest cellular network operator, NTT DoCoMo, is working with Intel and Samsung on development of the Tizen operating system and the first smartphone based on the platform could be out in Japan in 2013, according to a Japanese ...
Tags: NTT DoCoMo, Tizen operating system, smartphone, 2013
Halt Medical has obtained $15m finance from American Capital to support the commercialization of its Acessa system, designed for treating uterine fibroids. Using a slender Handpiece, the CE-marked system delivers radiofrequency energy to ...
Tags: Halt Medical, American Capital, commercialization, Acessa system
Amarantus BioScience has purchased all of the intellectual property (IP) assets from Power3 Medical Products. Power3 was in bankruptcy and the company has acquired the IP assets for $40,000 which includes technology related to the ...
Tags: Amarantus BioScience, intellectual property, Power3 Medical Products
Cardica has shipped its first commercial MicroCutter XCHANGE 30 devices and cartridges to DACH Medical, its distributor for Germany, Austria and Switzerland. The MicroCutter XCHANGE 30 is a cartridge-based cutting/stapling device, which ...
Tags: Cardica, MicroCutter, stapling device, initial shipment
OPKO Health has signed a definite agreement to acquire Sao Paulo, Brazil based pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos. The acquisition is expected to expand OPKO's ...
Tags: OPKO, pharmaceutical company, test cassettes, commercial synergies
BluGlass Ltd of Silverwater, Australia says that it has succeeded in its initial laboratory experiments in developing p-type gallium nitride (p-GaN) material (essential for making up the top layers of a nitride LED). Spun off from the ...
Tags: BluGlass RPCVD, Macquarie University, RPCVD, nitride LED
Ultraviolet light-emitting diode (UV LED) maker Sensor Electronic Technology Inc (SETi) of Columbia, SC, USA has been honored with the Tibbetts Award for the role it has played in R&D for the US Government under the Small Business ...
Tags: SensorElectronic, Technology, UV LEDs
Nitride Solutions Inc of Wichita, KS, USA, which is developing substrates for LEDs, lasers and power electronics, has been awarded a US National Science Foundation (NSF) grant of nearly $150,000 to commercialize its manufacturing ...
Tags: Nitride Solutions Inc, LEDs, AlN, substrates
PHP (Hypertext Preprocessor) is a well-established server-side dynamic language platform for Web development. Among its many users have been important Web properties such as SugarCRM and the Drupal content management system. Perhaps the top ...
Tags: PHP, Zend, CEO, enterprises
Halozyme Therapeutics has entered into collaboration and license agreement with Pfizer for the development and commercialization of subcutaneous biologics. The collaboration will focus on developing Pfizer biologics, leveraging Halozyme's ...
Tags: biologics, Halozyme Therapeutics, subcutaneous biologics, treatments
Bridgelux Inc.and Toshiba Corporation announced that Bridgelux and Toshiba have achieved the industry's top class 8"GaN on Silicon LED chip emitting 614mW,<3.1V@350mA with 1.1mm square chip,just months after they have engaged in a joint ...
Tags: Japan North America Toshiba LED Chip Bridgelux GaN on Silicon